Pla2g2f Molecule Protects Memory in Aging, Study Says

Meta description: An Italian-led study in the U.S. identifies Pla2g2f in mouse brains; opens path for therapies against cognitive decline and Alzheimer's, but human testing is needed.

Researchers led by an Italian working in the United States identified the molecule Pla2g2f in the hippocampus of mice and showed that it protects memory during aging, according to a report by ANSA published on October 16, 2026. The study, led by Cinzia Vicidomini, from Harvard Medical School, was published in the journal Nature Neuroscience.

Summary of the discovery

• The team detected the presence of Pla2g2f in neurons of the hippocampus, a brain region central to the formation and retention of memories.
• In mouse models, higher levels of the molecule were associated with better performance in memory tests during aging.
• According to ANSA, the research indicates that Pla2g2f acts as a protective agent against age-related cognitive decline.

Details of the study

• The authors observed that the gene linked to Pla2g2f becomes more active in response to aging and inflammatory processes in the brain, phenomena often associated with memory loss.
• The investigation combined genetic analyses, protein expression studies, and behavioral tests in mice to correlate the presence of the molecule with memory preservation.
• The work was published in the journal Nature Neuroscience; the first author is Cinzia Vicidomini, a researcher affiliated with Harvard Medical School. This information appears in ANSA's coverage of the study.

Implications and limitations

• The discovery opens up the possibility of developing therapies aimed at increasing or mimicking Pla2g2f's action to delay or prevent age-related cognitive decline and neurodegenerative diseases like Alzheimer's.
• The authors and the report emphasize that the findings are, for now, preclinical: obtained in mice and do not prove efficacy or safety in humans.
• Additional research is needed to:
  • understand the exact molecular mechanisms of Pla2g2f in the human brain;
  • assess possible side effects of increasing the molecule's levels;
  • test therapeutic strategies in controlled clinical trials.
• In a note cited by ANSA, scientists warn that artificially increasing gene expression in the nervous system can carry unpredictable risks, so validation steps are required before any clinical application.

Relevance for Brazilians and descendants of Italians

• The scientific leadership of an Italian researcher in a U.S. institution draws attention from Brazilians of Italian origin by highlighting the Italian diaspora's participation in cutting-edge global research.
• In Brazil, where the population is aging and the burden of neurodegenerative diseases is rising, advances pointing to new prevention or treatment strategies for Alzheimer’s have high public relevance.
• For readers interested in topics related to Italy, science, and life abroad, the study also speaks to themes found in sections such as Notícias da Itália and Vida na Itália.
• For readers following topics on ancestry and citizenship, the connection with Italian researchers abroad reinforces scientific ties that may interest those visiting content on Cidadania Italiana.

What comes next

• The natural next steps include replication of results by other groups, investigations into the presence and function of Pla2g2f in human brains, and, if preclinical data remain promising, the design of clinical trials to evaluate safety and efficacy.
• Translational research and international collaborations will be essential to translate this basic discovery into viable therapeutic interventions.

Conclusion: The finding that Pla2g2f protects memory in animal models represents a promising advance in understanding the mechanisms of resistance to cognitive decline with aging, but it remains distant from clinical application until human studies demonstrate safety and benefit.

Source: ANSA